Glycolysis
- Compartment
- Cytosol
- Main tissue
- All cells; esp. RBC, muscle, brain
- Rate-limiting
- Phosphofructokinase-1 (PFK-1)
- Steps
- 10
Reaction steps
In source order, 10 total
-
1
Glucose + ATP -> glucose-6-phosphate + ADP
In Glucose› Notes
Hexokinase I–III in most tissues, or glucokinase (hexokinase IV) in liver and pancreatic beta cells, transfers the terminal phosphate of ATP to glucose; Mg2+ is required. This is an irreversible trapping step; it is not the committed step because glucose-6-phosphate can enter glycogenesis or the pentose phosphate pathway. Hexokinase is product-inhibited by glucose-6-phosphate, whereas glucokinase has a high Km and high Vmax and is regulated by glucokinase regulatory protein in hepatocytes.
-
2
Glucose-6-phosphate → fructose-6-phosphate
› Notes
Phosphoglucose isomerase catalyzes reversible aldose–ketose isomerization through an enediol intermediate; no nucleotide cofactor is consumed. This reversible reaction prepares the molecule for symmetrical cleavage after a second phosphorylation.
-
3
Fructose-6-phosphate + ATP -> fructose-1,6-bisphosphate + ADP
› Notes
Phosphofructokinase-1 (PFK-1) uses ATP and Mg2+. This is the principal rate-limiting, committed, and irreversible step of glycolysis; fructose-1,6-bisphosphate is committed to glycolytic cleavage rather than glucose-6-phosphate-dependent alternative pathways.
-
4
Fructose-1,6-bisphosphate → glyceraldehyde-3-phosphate + dihydroxyacetone phosphate
› Notes
Fructose-bisphosphate aldolase reversibly cleaves the six-carbon ketose bisphosphate into two phosphorylated trioses. No redox cofactor or ATP is required.
-
5
Dihydroxyacetone phosphate → glyceraldehyde-3-phosphate
› Notes
Triose phosphate isomerase reversibly interconverts the two trioses through an enediol intermediate. Only glyceraldehyde-3-phosphate continues directly through the payoff reactions, so one glucose yields two glyceraldehyde-3-phosphate molecules from this point onward.
-
6
Glyceraldehyde-3-phosphate + inorganic phosphate + NAD+ → 1,3-bisphosphoglycerate + NADH + H+
› Notes
Glyceraldehyde-3-phosphate dehydrogenase oxidizes the aldehyde and captures the energy in an acyl-phosphate bond; it requires NAD+ and free inorganic phosphate (Pi). The reaction is reversible. Because it occurs twice per glucose, it generates two cytosolic NADH.
-
7
1,3-Bisphosphoglycerate + ADP → 3-phosphoglycerate + ATP
› Notes
Phosphoglycerate kinase requires Mg2+ and catalyzes reversible substrate-level phosphorylation. Occurring twice per glucose, this first payoff reaction produces two ATP and thereby repays the two ATP invested in steps 1 and 3.
-
8
3-Phosphoglycerate → 2-phosphoglycerate
› Notes
Phosphoglycerate mutase reversibly shifts the phosphate from carbon 3 to carbon 2; the 2,3-bisphosphoglycerate-dependent isoenzyme requires a catalytic phosphohistidine and 2,3-bisphosphoglycerate for priming. No ATP is consumed.
-
9
2-Phosphoglycerate → phosphoenolpyruvate + H2O
› Notes
Enolase requires Mg2+ (or Mn2+) and reversibly dehydrates 2-phosphoglycerate to form phosphoenolpyruvate (PEP), a compound with high phosphoryl-transfer potential. Fluoride inhibits enolase and is used to limit glycolysis in some blood collection tubes.
-
10
Phosphoenolpyruvate + ADP → pyruvate + ATP
› Notes
Pyruvate kinase requires K+ and Mg2+ (or Mn2+) and performs the second substrate-level phosphorylation. This step is irreversible; in liver it is an important regulatory point and is activated feed-forward by fructose-1,6-bisphosphate. It occurs twice per glucose and yields two additional ATP.
Showing all 10 steps.
Regulation
What speeds each enzyme up and what slows it down
Hexokinase I–III
Availability of glucose
Glucose-6-phosphate
No major acute direct hormonal regulation
Glucokinase (liver)
High portal glucose; release from glucokinase regulatory protein by fructose-1-phosphate
Fructose-6-phosphate promotes nuclear sequestration through glucokinase regulatory protein
Insulin induces expression; glucagon lowers expression during fasting
Phosphofructokinase-1
AMP, ADP, fructose-2,6-bisphosphate
ATP, citrate, low pH (especially muscle)
Insulin increases hepatic fructose-2,6-bisphosphate through dephosphorylated PFK-2/FBPase-2; glucagon lowers it via protein kinase A
Pyruvate kinase (liver isoform)
Fructose-1,6-bisphosphate
ATP, alanine; phosphorylation
Insulin promotes dephosphorylation and activity; glucagon/epinephrine activate protein kinase A, phosphorylating and inhibiting the liver isoform
Overview
Glycolysis is the cytosolic sequence that converts one molecule of glucose to two molecules of pyruvate (or, when mitochondrial oxidation is limited, lactate), conserving energy as ATP and NADH. It supplies rapid ATP in every cell and is indispensable in cells without mitochondria, notably erythrocytes; its intermediates also feed biosynthetic pathways. The pathway has an energy-investment phase (steps 1–5) and an energy-payoff phase (steps 6–10).
Cellular location
All ten reactions occur in the cytosol. Glycolytic flux is especially high in exercising skeletal muscle, erythrocytes, renal medulla, brain, leukocytes, and many proliferating cells; hepatocytes use glycolysis prominently in the fed, insulinized state. Cytosolic NADH produced by glycolysis is reoxidized through the malate–aspartate or glycerol 3-phosphate shuttle under aerobic conditions, or by lactate dehydrogenase under anaerobic conditions.
Net energetics
Per glucose converted to two pyruvate, glycolysis consumes 2 ATP (steps 1 and 3) and forms 4 ATP (steps 7 and 10), for net 2 ATP by substrate-level phosphorylation. It also produces 2 NADH + 2 H+ and 2 H2O; no NADPH, FADH2, or GTP is produced. The net reaction is: glucose + 2 ADP + 2 Pi + 2 NAD+ → 2 pyruvate + 2 ATP + 2 NADH + 2 H+ + 2 H2O; under anaerobic conditions, pyruvate + NADH → lactate + NAD+ regenerates NAD+ without additional ATP.
Clinical significance
Glycolysis is the sole ATP-producing pathway available to mature erythrocytes and a major rapid-energy source in hypoxic or intensely exercising tissue. Aerobic tumor cells frequently exhibit high glycolytic flux and lactate formation despite oxygen availability (the Warburg effect), which supports anabolic precursor generation and is the basis of fluorodeoxyglucose positron-emission tomography. Pyruvate kinase deficiency reduces erythrocyte ATP, causing chronic nonspherocytic hemolytic anemia; phosphofructokinase deficiency (Tarui disease) causes exercise intolerance and hemolysis.
Recent literature
Live Europe PMC search
Europe PMC · fetched just now · sorted by publication date
-
1
Advances and perspectives in genetically encoded biosensors for biomarker detection and theranostic circuits.
Xu J, Qi Q, Wang Q. · 2026-09-23
open access unreviewed -
2
Strategies and applications for alleviating carbon catabolite repression.
Lu M, Ding H, Zhang H, Xu J, Meng R, Li Y, Zhang Z, Zheng P, Zhu Y, Sun J. · 2026-08-20
open access unreviewed -
3
EINN: An enzyme-informed neural network guided by an enzyme-constrained genome-scale metabolic model.
Steven R, Kimata K, Chegodaev D, Handayani L, Satou K. · 2026-08-06
open access unreviewed -
4
Immuno-resolving nitric oxide-generating stents for coordinated vascular healing.
Du Z, Yang M, Huang Y, Ma Q, Mou X, Zhang W, Wang Y, Zhu J, Yang Z. · 2026-09-15
open access unreviewed -
5
Dismantling the eDNA-mediated H<sub>2</sub>S barrier with biohybrids against refractory biofilm infections.
Yin M, Su M, Yi J, Ren Y, Zhang Y, Wu Q, Yang C, Xiao S, Gao C, Tang R, Cheng B, Xia J. · 2026-09-15
open access unreviewed -
6
A programmable spatiotemporal bioelectrical conduit promotes peripheral nerve regeneration by suppressing ferroptosis through modulation of ER-mitochondria coupling in Schwann cells.
Wang Z, Jiang A, Wang F, Yang Z, Zhong Y, Yang Y, Tan J, Han W, Li X, He X, Zhang X, Wang J, Han X, Bai D. · 2026-09-16
open access unreviewed -
7
A transferrin receptor-targeted liposome for iron metabolism regulation-augmented photodynamic therapy in glioblastoma.
Wen R, He G, Wan Y, Guo X, Xiong S, Wu Y, Wei Y, Li D, Lin J, Huang P. · 2026-09-16
open access unreviewed -
8
Click chemistry-modified cardiomyocytes enhance cardiac contractility and prevent remodeling in ischemia-reperfusion injured hearts.
Lee D, Sim WS, Park JH, Han DY, Kim SJ, An JR, Seo MS, Kim JJ, Cheon SY, Hong H, Choi SW, Ban K, Koo H, Park … · 2026-09-16
open access unreviewed -
9
Multienzymatic hybrid bio-heterojunction for synergistic microenvironment reprogramming and selenoprotein-activated mitochondrial bioenergetics in diabetic osseointegration.
Zhang M, Lu M, Chen Y, Ming M, Luo B, Wu Y. · 2026-09-16
open access unreviewed -
10
Engineering bioactive citrate-based hydrogels for wound repair: From structure-function design to microenvironmental regulation.
Zhang L, Lei B, Zhao H. · 2026-09-08
open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.